Publicaciones en las que colabora con José Vivancos Mora (6)

2009

  1. Synthesis of lipoxin A 4 by 5-lipoxygenase mediates pparγ-dependent, neuroprotective effects of rosiglitazone in experimental stroke

    Journal of Neuroscience, Vol. 29, Núm. 12, pp. 3875-3884

2008

  1. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke

    Circulation, Vol. 118, Núm. 14, pp. 1450-1459

2007

  1. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARγ target gene involved in neuroprotection

    Journal of Cerebral Blood Flow and Metabolism, Vol. 27, Núm. 7, pp. 1327-1338

2006

  1. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke

    Journal of Experimental Medicine, Vol. 203, Núm. 3, pp. 711-717

  2. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms

    Journal of Cerebral Blood Flow and Metabolism, Vol. 26, Núm. 2, pp. 218-229

2005

  1. The nonthiazolidinedione PPARγ agonist L-796,449 is neuroprotective in experimental stroke

    Journal of Neuropathology and Experimental Neurology, Vol. 64, Núm. 9, pp. 797-805